8-K Impact 8/10 Earnings

$IONQ · IonQ, Inc.

November 5, 2026 · AI-analyzed SEC filing · Verify material figures against the official SEC.gov filing

IonQ's 8-K reports Q3 FY2026 results (quarter ended September 30, 2026) and the November 3, 2026 completion of its all-stock acquisition of Elisity, Inc. Revenue was $173.8M, up 336% YoY, with GAAP EPS of $1.35 diluted and Adjusted EPS of ($0.29). The company raised FY2026 revenue guidance to $505-$515M and reported $3.7B in pro-forma cash and investments. The Elisity deal involved 32.23M shares of closing consideration plus up to 4.27M earn-out shares.

  • Q3 revenue of $173.8M, up 336% YoY, sixth consecutive record quarter
  • FY2026 revenue guidance raised to $505-$515M, expecting 110% YoY quantum computing growth
  • Remaining performance obligations more than doubled to $1.2B
  • GAAP net income of $564.0M driven by $896.2M non-cash warrant fair-value gain
  • Elisity acquisition closed for 32.23M shares plus up to 4.27M earn-out shares
PeriodQ3 FY2026
ResultBeat
Revenue$173.8M
Revenue YoY+336%
EPS$(0.29)
Net income$563.1M
Guidance rev$505-$515M

Extended-hours last trade of $27.70, up 4.81% vs the $26.43 regular close, signaling a positive after-hours reaction to the beat and guidance raise.

IonQ delivered a triple catalyst — record revenue, raised guidance, and a completed acquisition — while its $1.2B backlog signals durable demand.

IonQ positions itself as the best-capitalized pure-play quantum company with $3.7B pro-forma cash, and claims the only trapped-ion company to reach DARPA's Quantum Benchmarking Initiative Stage C (up to $300M potential value).

GAAP profitability is driven by a non-cash $896.2M warrant fair-value gain; core operations still show a $433.1M operating loss and Adjusted EBITDA of ($133.6M). The Elisity earn-out adds up to 4.27M shares of potential dilution through January 2028.

Get filings like this before the market reacts.

Real-time SEC filing alerts, AI summaries, and a free daily digest — plus portfolio tracking that ties filings to your positions.

Start your free trial →